PTCT(PTC Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $538.59M | $698.80M | $937.82M | $806.78M | $1.73B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$374.44M | −$447.41M | −$439.50M | −$302.57M | $866.93M |
| 净利润 | −$523.90M | −$559.02M | −$626.60M | −$363.30M | $682.64M |
| 经营现金流 | −$251.33M | −$356.65M | −$158.42M | −$107.69M | $711.20M |
| 自由现金流 | −$279.55M | −$388.67M | −$186.86M | −$114.19M | $702.34M |
| 摊薄每股收益 | $-7.43 | $-7.79 | $-8.37 | $-4.73 | $7.78 |